Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 7/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.69 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 3/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21694054 | 0.94 | TSHR (0.65) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL244114 | 0.85 | TSHR (0.95) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL8493780 | 0.83 | TSHR (1.00) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL33725 | 0.83 | TSHR (1.00) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL482460 | 0.83 | TSHR (1.00) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL9101988 | 0.83 | TSHR (1.00) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL13945622 | 0.83 | TSHR (1.00) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| Ethylene SCHEMBL977945 | 0.83 | TSHR (0.90) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL20873747 | 0.83 | TSHR (1.00) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL322713 | 0.83 | TSHR (1.00) | TSHRALDH1A1CYP3A4HPGDTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10774062-B2 | Photocuring method, compound and composition used therein | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2020-09-15 | — | — | US | disclosed |
| EP-3409709-B1 | PHOTOCURING METHOD, COMPOUND AND COMPOSITION USED THEREIN | FUJIFILM WAKO PURE CHEMICAL CORP (JP) | 2020-08-19 | — | — | EP | disclosed |
| US-20190055210-A1 | PHOTOCURING METHOD, COMPOUND AND COMPOSITION USED THEREIN | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2019-02-21 | — | — | US | disclosed |
| EP-3409709-A1 | PHOTOCURING METHOD, COMPOUND AND COMPOSITION USED THEREIN | FUJIFILM Wako Pure Chemical Corporation (JP) | 2018-12-05 | — | — | EP | disclosed |
| EP-2005236-B1 | SPD LIGHT VALVES INCORPORATING FILMS COMPRISING IMPROVED MATRIX POLYMERS AND METHODS FOR MAKING SUCH MATRIX POLYMERS | RESEARCH FRONTIERS INC (US) | 2018-02-07 | — | — | EP | disclosed |
| US-8299185-B2 | Curable cage-type silicone copolymer and process for production thereof and curable resin composition comprising curable cage-type silicone copolymer and cured product thereof | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2012-10-30 | — | — | US | disclosed |
| US-20100280190-A1 | CURABLE CAGE-TYPE SILICONE COPOLYMER AND PROCESS FOR PRODUCTION THEREOF AND CURABLE RESIN COMPOSITION COMPRISING CURABLE CAGE-TYPE SILICONE COPOLYMER AND CURED PRODUCT THEREOF | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2010-11-04 | — | — | US | disclosed |
| EP-2005236-A2 | SPD LIGHT VALVES INCORPORATING FILMS COMPRISING IMPROVED MATRIX POLYMERS AND METHODS FOR MAKING SUCH MATRIX POLYMERS | RESEARCH FRONTIERS INCORPORATED (US) | 2008-12-24 | — | — | EP | disclosed |
| WO-2007097796-A2 | SPD LIGHT VALVES INCORPORATING FILMS COMPRISING IMPROVED MATRIX POLYMERS AND METHODS FOR MAKING SUCH MATRIX POLYMERS | RESEARCH FRONTIERS INCORPORATED (US) | 2007-08-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190055210-A1 | PHOTOCURING METHOD, COMPOUND AND COMPOSITION USED THEREIN | ESD, TMT1A, PAM | TSHR 4741/4885ALDH1A1 23/4885CYP3A4 2435/4885 |
| US-10774062-B2 | Photocuring method, compound and composition used therein | ESD, TMT1A, PAM | TSHR 4741/4885ALDH1A1 23/4885CYP3A4 2435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.